Nermin E. Eleraky

836 total citations
19 papers, 593 citations indexed

About

Nermin E. Eleraky is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Nermin E. Eleraky has authored 19 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 5 papers in Molecular Biology and 5 papers in Biomaterials. Recurrent topics in Nermin E. Eleraky's work include Advanced Drug Delivery Systems (9 papers), Advancements in Transdermal Drug Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Nermin E. Eleraky is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Advancements in Transdermal Drug Delivery (6 papers) and Nanoparticle-Based Drug Delivery (5 papers). Nermin E. Eleraky collaborates with scholars based in Egypt, Saudi Arabia and United States. Nermin E. Eleraky's co-authors include M. Omar, Ayat Allam, Mahmoud Elsabahy, Heba A. Abou‐Taleb, Ghareb M. Soliman, Mohamed A. Safwat, Mohamed Elnaggar, Aml I. Mekkawy, Giovanni M. Pauletti and Mohamed A. Attia and has published in prestigious journals such as Scientific Reports, International Journal of Pharmaceutics and International Journal of Nanomedicine.

In The Last Decade

Nermin E. Eleraky

18 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nermin E. Eleraky Egypt 10 220 175 114 104 96 19 593
Ayat Allam Egypt 15 448 2.0× 209 1.2× 125 1.1× 148 1.4× 113 1.2× 22 901
Linghui Dian China 8 225 1.0× 205 1.2× 77 0.7× 171 1.6× 56 0.6× 10 585
Behiye Şenel Türkiye 13 198 0.9× 145 0.8× 86 0.8× 164 1.6× 99 1.0× 26 556
Karimunnisa S. Shaikh India 15 293 1.3× 181 1.0× 65 0.6× 153 1.5× 54 0.6× 26 678
Fhataheya Buang Malaysia 15 138 0.6× 170 1.0× 84 0.7× 132 1.3× 109 1.1× 26 700
Heba A. Hazzah Egypt 12 277 1.3× 141 0.8× 57 0.5× 125 1.2× 45 0.5× 17 624
Pragya Yadav India 11 229 1.0× 109 0.6× 118 1.0× 95 0.9× 89 0.9× 22 554
Mahendra Singh India 16 208 0.9× 163 0.9× 50 0.4× 105 1.0× 54 0.6× 38 749
Neha Mallick India 9 266 1.2× 184 1.1× 58 0.5× 139 1.3× 49 0.5× 11 602
Vaibhav Rastogi India 12 274 1.2× 105 0.6× 127 1.1× 113 1.1× 104 1.1× 45 600

Countries citing papers authored by Nermin E. Eleraky

Since Specialization
Citations

This map shows the geographic impact of Nermin E. Eleraky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nermin E. Eleraky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nermin E. Eleraky more than expected).

Fields of papers citing papers by Nermin E. Eleraky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nermin E. Eleraky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nermin E. Eleraky. The network helps show where Nermin E. Eleraky may publish in the future.

Co-authorship network of co-authors of Nermin E. Eleraky

This figure shows the co-authorship network connecting the top 25 collaborators of Nermin E. Eleraky. A scholar is included among the top collaborators of Nermin E. Eleraky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nermin E. Eleraky. Nermin E. Eleraky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hofny, Eman R. M., et al.. (2025). Comparative study of different treatment modalities for melasma: introducing a novel nanotechnology-based tranexamic acid microemulsion. Archives of Dermatological Research. 317(1). 792–792.
2.
Eleraky, Nermin E., et al.. (2024). Sertaconazole-PLGA nanoparticles for management of ocular keratitis. Journal of Drug Delivery Science and Technology. 95. 105539–105539. 6 indexed citations
3.
Eleraky, Nermin E., et al.. (2024). Prednisolone loaded-cationic nanoemulsion formulation for uveitis management. Journal of Drug Delivery Science and Technology. 92. 105406–105406. 8 indexed citations
4.
Eleraky, Nermin E., et al.. (2024). Rosuvastatin Flexible Chitosomes: Development, In Vitro Evaluation and Enhancement of Anticancer Efficacy Against HepG2 and MCF7 Cell Lines. AAPS PharmSciTech. 25(7). 234–234. 2 indexed citations
5.
Eleraky, Nermin E., et al.. (2023). Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2. International Journal of Nanomedicine. Volume 18. 5831–5869. 8 indexed citations
6.
Eleraky, Nermin E., et al.. (2022). Design and optimization of metformin hydrophobic ion pairs for efficient encapsulation in polymeric drug carriers. Scientific Reports. 12(1). 5737–5737. 21 indexed citations
7.
Abdellatif, Ahmed A. H., et al.. (2022). Transethosomal Gel for the Topical Delivery of Celecoxib: Formulation and Estimation of Skin Cancer Progression. Pharmaceutics. 15(1). 22–22. 21 indexed citations
8.
Mekkawy, Aml I., et al.. (2022). Combinatorial Therapy of Letrozole- and Quercetin-Loaded Spanlastics for Enhanced Cytotoxicity against MCF-7 Breast Cancer Cells. Pharmaceutics. 14(8). 1727–1727. 38 indexed citations
9.
Allam, Ayat, Nermin E. Eleraky, Mahmoud Elsabahy, et al.. (2022). Development of Sedative Dexmedetomidine Sublingual In Situ Gels: In Vitro and In Vivo Evaluations. Pharmaceutics. 14(2). 220–220. 9 indexed citations
10.
Allam, Ayat, et al.. (2021). Betaxolol‐loaded niosomes integrated within pH‐sensitive in situ forming gel for management of glaucoma. International Journal of Pharmaceutics. 598. 120380–120380. 74 indexed citations
11.
Omar, M., et al.. (2021). Externally Triggered Novel Rapid-Release Sonosensitive Folate-Modified Liposomes for Gemcitabine: Development and Characteristics. International Journal of Nanomedicine. Volume 16. 683–700. 13 indexed citations
12.
Eleraky, Nermin E., et al.. (2020). Permeation-Enhancing Nanoparticle Formulation to Enable Oral Absorption of Enoxaparin. AAPS PharmSciTech. 21(3). 88–88. 24 indexed citations
13.
Eleraky, Nermin E., et al.. (2020). Nanomedicine Fight against Antibacterial Resistance: An Overview of the Recent Pharmaceutical Innovations. Pharmaceutics. 12(2). 142–142. 241 indexed citations
14.
Safwat, Mohamed A., et al.. (2020). Epigallocatechin-3-Gallate-Loaded Gold Nanoparticles: Preparation and Evaluation of Anticancer Efficacy in Ehrlich Tumor-Bearing Mice. Pharmaceuticals. 13(9). 254–254. 38 indexed citations
15.
Eleraky, Nermin E., et al.. (2020). Nanostructured Lipid Carriers to Mediate Brain Delivery of Temazepam: Design and In Vivo Study. Pharmaceutics. 12(5). 451–451. 68 indexed citations
16.
Eleraky, Nermin E., Gihan Fetih, & Mahmoud El‐Badry. (2019). PERFORMANCE OF QUERCETIN-CHITOSAN GELS AS TOPICAL DELIVERY SYSTEMS. Bulletin of Pharmaceutical Sciences Assiut. 42(1). 71–79. 2 indexed citations
17.
Omar, M. & Nermin E. Eleraky. (2017). Formulation And Evaluation Of The Prepared Floating Raft System Of Tizanidine HCL. 5(6). 392–408. 2 indexed citations
18.
Eleraky, Nermin E., et al.. (2015). Hydrophobic Ion-Pairing of Low Molecular Weight Heparin with Cetyltrimethylammonium Bromide. 5 indexed citations
19.
Ali, Hany S.M., et al.. (2011). ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF DOMPERIDONE BY UTILIZING DIFFERENT TECHNIQUES. Bulletin of Pharmaceutical Sciences Assiut. 34(2). 105–120. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ayat Allam Breakdown of academic impact, for papers by Linghui Dian Breakdown of academic impact, for papers by Behiye Şenel Breakdown of academic impact, for papers by Karimunnisa S. Shaikh Breakdown of academic impact, for papers by Fhataheya Buang Breakdown of academic impact, for papers by Heba A. Hazzah Breakdown of academic impact, for papers by Pragya Yadav Breakdown of academic impact, for papers by Mahendra Singh Breakdown of academic impact, for papers by Neha Mallick Breakdown of academic impact, for papers by Vaibhav Rastogi
Rankless by CCL
2026